HFG
PFE icon

Heron Financial Group’s Pfizer PFE Stock Holding History

Heron Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$518K Buy
14,110
+215
+2% +$8.37K 0.28% 81
2023
Q1 		$567K Sell
13,895
-570
-4% -$24.6K 0.31% 73
2022
Q4 		$718K Sell
14,465
-690
-5% -$33.1K 0.48% 46
2022
Q3 		$663K Buy
15,155
+480
+3% +$23.3K 0.41% 54
2022
Q2 		$769K Sell
14,675
-3,705
-20% -$189K 0.47% 47
2022
Q1 		$952K Buy
18,380
+2,528
+16% +$131K 0.5% 43
2021
Q4 		$841K Sell
15,852
-782
-5% -$38.7K 0.45% 49
2021
Q3 		$715K Sell
16,634
-1,043
-6% -$46.2K 0.4% 52
2021
Q2 		$692K Buy
17,677
+825
+5% +$32.1K 0.4% 57
2021
Q1 		$612K Sell
16,852
-45
-0.3% -$1.6K 0.37% 61
2020
Q4 		$626K Sell
16,897
-949
-5% -$34.8K 0.43% 58
2020
Q3 		$622K Sell
17,846
-1,934
-10% -$67.8K 0.5% 49
2020
Q2 		$635K Sell
19,780
-1,263
-6% -$42.9K 0.57% 44
2020
Q1 		$728K Sell
21,043
-802
-4% -$27.3K 0.75% 34
2019
Q4 		$789K Buy
+21,845
New +$778K 0.65% 40

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Heron Financial Group's PFE Position: Q2 2023 in Review

Heron Financial Group increased its Pfizer (PFE) stake by 1.5% in Q2 2023, buying an estimated $8.37K and bringing the position to 14,110 shares worth $518K. The position accounts for 0.28% of the portfolio, ranked #81.

Heron Financial Group first reported a position in PFE in Q4 2019 and has held it in 15 quarters since. The position peaked at $952K in Q1 2022. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Heron Financial Group held 14,110 shares of Pfizer worth $518K as of Q2 2023.
  • Heron Financial Group bought 215 Pfizer shares in Q2 2023, an estimated $8.37K.
  • Pfizer made up 0.28% of Heron Financial Group's portfolio in Q2 2023, its #81 holding.
  • Heron Financial Group first reported a position in Pfizer in Q4 2019 and has held it in 15 quarters since.
  • Heron Financial Group's Pfizer position peaked at $952K in Q1 2022.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Heron Financial Group's 13F filing for Q2 2023, filed 10 Aug 2023.